Humira facing building pressure in EU as Samsung, Biogen get nod for biosimilar
admin 23rd June 2017 Uncategorised 0A new flank is opening up in the assault on Humira, the world’s best-selling drug, as the European Medicines Agency today recommended approval of Imraldi, a Humira biosimilar from Samsung and Biogen.
More: Humira facing building pressure in EU as Samsung, Biogen get nod for biosimilar
Source: fierce